VedaBio
YC S21 ↗San Diego, US · Founded 2021 · 30 employees · 3 known investors
VedaBio develops a molecular detection platform using CRISPR technology that enables rapid, accurate detection of multiple biological targets without the need for amplification. The platform serves research, diagnostics, and industrial applications across multiple markets.
AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesHard Techin /labsimply/@ycombinatorycombinator.com ↗
Founders & leadership· Y Combinator alumni (S21)
AG
Anurup GanguliinFounder
F
FredPresident and CEO
FS
Frédéric SweeneyPresident and Chief Executive Officer
ME
Maurice ExnerChief Operating Officer
Investors · 3
In the news
- VedaBio Focused on Product Development with New Strategic Partnerships - San Diego Business Journalsdbj.com · 2025
- Siemens Healthineers enters CRISPR diagnostics space - European Biotechnology Magazineeuropean-biotechnology.com · 2025
- VedaBio: Significant Funding Secured And Strategic Partnership Signed Advance Molecular Diagnosticspulse2.com · 2025
- VedaBio Announces Strategic Agreement with Siemens Healthineers and Series A Extension, Totaling Up to $25 Million - BioSpacebiospace.com · 2025
- VedaBio Launches With Over $40M in Initial Fundingfinsmes.com · 2023